b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31889362</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>06</Month>\n            <Day>15</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1872-8081</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>46</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>May</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>BioFactors (Oxford, England)</Title>\n                <ISOAbbreviation>Biofactors</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Long noncoding RNA-GAS5 attenuates progression of glioma by eliminating microRNA-10b and Sirtuin 1 in U251 and A172 cells.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>487-496</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1002/biof.1604</ELocationID>\n            <Abstract>\n                <AbstractText>Long noncoding RNA (lncRNA) growth arrest-specific 5 (GAS5) is implicated in several cancers via modulating microRNAs (miRs). However, little information is available about the correlation between GAS5 and miR-10b. Therefore, we sought out to investigate the biological role of GAS5-miR-10b node mainly in glioma cells. We artificially modulated GAS5 to explore its roles in viability assayed by cell counting kit-8 (CCK-8), motile activities by 24-Transwell assay, as well as apoptosis by a flow cytometer and Western blot assay. miR-10b and Sirtuin 1 (Sirt1) were quantified by qRT-PCR. After co-transfection, we analyzed the viability, migration, invasion, apoptosis, and Sirt1 expression. Western blot was implemented to detect the phosphorylated forms of PTEN, PI3K, AKT, MEK, and ERK. GAS5 inhibited proliferation and motile behaviors, and fortified apoptosis. As for the viability and motile activities, the property of GAS5 was reversed in miR-10b-replenished U251 and A172 cells, while maintained in miR-10b-deficient cells. Additionally, GAS5-induced apoptosis was abolished by miR-10b overexpression while fortified by miR-10b silence. Besides, GAS5 negatively modulated Sirt1 via miR-10b. Moreover, Sirt1 negatively modulated PTEN and positively mediated the abovementioned regulators. GAS5 represses the process of glioma cells by decreasing miR-10b, which as accompanied by Sirt1 silence-induced inactivation of PTEN/PI3K/AKT and MEK/ERK cascades.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 2019 International Union of Biochemistry and Molecular Biology.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Ding</LastName>\n                    <ForeName>Yingjie</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Wang</LastName>\n                    <ForeName>Jing</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Zhang</LastName>\n                    <ForeName>Hongliang</ForeName>\n                    <Initials>H</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Li</LastName>\n                    <ForeName>Huanting</ForeName>\n                    <Initials>H</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0001-9764-6315</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurosurgery, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <GrantList CompleteYN="Y">\n                <Grant>\n                    <GrantID>2018WS385</GrantID>\n                    <Agency>Projects of Medical and Health Technology Development Program of Shandong Province</Agency>\n                    <Country/>\n                </Grant>\n            </GrantList>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>30</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Netherlands</Country>\n            <MedlineTA>Biofactors</MedlineTA>\n            <NlmUniqueID>8807441</NlmUniqueID>\n            <ISSNLinking>0951-6433</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">GAS5</Keyword>\n            <Keyword MajorTopicYN="N">Sirt1</Keyword>\n            <Keyword MajorTopicYN="N">glioma</Keyword>\n            <Keyword MajorTopicYN="N">miR-10b</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>11</Month>\n                <Day>15</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>12</Month>\n                <Day>13</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31889362</ArticleId>\n            <ArticleId IdType="doi">10.1002/biof.1604</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Title>REFERENCES</Title>\n            <Reference>\n                <Citation>Hoelzinger DB, Demuth T, Berens ME. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst. 2007;99:1583-1593.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Pessina F, Navarria P, Cozzi L, et al. Value of surgical resection in patients with newly diagnosed grade III glioma treated in a multimodal approach: Surgery, chemotherapy and radiotherapy. Ann Surg Oncol. 2016;23:3040-3046.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Di Cristofori A, Zarino B, Fanizzi C, et al. Analysis of factors influencing the access to concomitant chemo-radiotherapy in elderly patients with high grade gliomas: Role of MMSE, age and tumor volume. J Neurooncol. 2017;134:377-385.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Roccograndi L, Binder ZA, Zhang L, et al. SHP2 regulates proliferation and tumorigenicity of glioma stem cells. J Neurooncol. 2017;135:487-496.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Caja L, Tzavlaki K, Dadras MS, et al. Snail regulates BMP and TGFbeta pathways to control the differentiation status of glioma-initiating cells. Oncogene. 2018;37:2515-2531.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Xue Y, Ni T, Jiang Y, Li Y. Long noncoding RNA GAS5 inhibits tumorigenesis and enhances radiosensitivity by suppressing miR-135b expression in non-small cell lung cancer. Oncol Res. 2017;25:1305-1316.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Avgeris M, Tsilimantou A, Levis PK, et al. Loss of GAS5 tumour suppressor lncRNA: An independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients. Br J Cancer. 2018;119:1477-1486.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhao X, Wang P, Liu J, et al. Gas5 exerts tumor-suppressive functions in human glioma cells by targeting miR-222. Mol Ther. 2015;23:1899-1911.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Zhao X, Liu Y, Zheng J, et al. GAS5 suppresses malignancy of human glioma stem cells via a miR-196a-5p/FOXO1 feedback loop. Biochim Biophys Acta Mol Cell Res. 2017;1864:1605-1617.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Liu Q, Yu W, Zhu S, et al. Long noncoding RNA GAS5 regulates the proliferation, migration, and invasion of glioma cells by negatively regulating miR-18a-5p. J Cell Physiol. 2018;234:757-768.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007;449:682-688.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ma L, Reinhardt F, Pan E, et al. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol. 2010;28:341-347.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Guessous F, Alvarado-Velez M, Marcinkiewicz L, et al. Oncogenic effects of miR-10b in glioblastoma stem cells. J Neurooncol. 2013;112:153-163.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int J Cancer. 2009;125:1407-1413.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sun L, Yan W, Wang Y, et al. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res. 2011;1389:9-18.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Song J, Ahn C, Chun CH, Jin EJ. A long non-coding RNA, GAS5, plays a critical role in the regulation of miR-21 during osteoarthritis. J Orthop Res. 2014;32:1628-1635.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Imai S, Yoshino J. The importance of NAMPT/NAD/SIRT1 in the systemic regulation of metabolism and ageing. Diabetes Obes Metabol. 2013;15(suppl 3):26-33.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Knight JR, Milner J. SIRT1, metabolism and cancer. Curr Opin Oncol. 2012;24:68-75.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Choi I, Rickert E, Fernandez M, Webster NJG. SIRT1 in astrocytes regulates glucose metabolism and reproductive function. Endocrinology. 2019;160:1547-1560.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Saidi D, Cheray M, Osman AM, et al. Glioma-induced SIRT1-dependent activation of hMOF histone H4 lysine 16 acetyltransferase in microglia promotes a tumor supporting phenotype. Oncoimmunology. 2018;7:e1382790.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Chen WY, Wang DH, Yen RC, Luo J, Gu W, Baylin SB. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell. 2005;123:437-448.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Herranz D, Munoz-Martin M, Canamero M, et al. Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer. Nat Commun. 2010;1:3.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Qu Y, Zhang J, Wu S, Li B, Liu S, Cheng J. SIRT1 promotes proliferation and inhibits apoptosis of human malignant glioma cell lines. Neurosci Lett. 2012;525:168-172.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene. 2009;28:195-208.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Qiao HP, Gao WS, Huo JX, Yang ZS. Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J Cancer Prev. 2013;14:1077-1082.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Sun M, Jin FY, Xia R, et al. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer. 2014;14:319.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Georgescu, Maria-Magdalena. PTEN tumor suppressor network in PI3K-Akt pathway control. Genes &amp; Cancer. 2010;12:1170-1177.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kwon SJ, Kwon OS, Kim KT, et al. Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii. Molecular Cancer. 2017;16:140.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Williams GT, Hughes JP, Stoneman V, et al. Isolation of genes controlling apoptosis through their effects on cell survival. Gene Ther Mol Biol. 2006;10:255-262.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Kino T, Hurt DE, Ichijo T, Nader N, Chrousos GP. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci Signal. 2010;3:ra8.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Jalali S, Bhartiya D, Lalwani MK, Sivasubbu S, Scaria V. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One. 2013;8:e53823.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Cheng F, Su L, Yao C, et al. SIRT1 promotes epithelial-mesenchymal transition and metastasis in colorectal cancer by regulating Fra-1 expression. Cancer Lett. 2016;375:274-283.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Ferrer CM, Lu TY, Bacigalupa ZA, Katsetos CD, Sinclair DA, Reginato MJ. O-GlcNAcylation regulates breast cancer metastasis via SIRT1 modulation of FOXM1 pathway. Oncogene. 2017;36:559-569.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Chen H, Lu Q, Fei X, Shen L, Jiang D, Dai D. miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1. Tumour Biol. 2016;37:6761-6768.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Li C, Liu Z, Yang K, et al. miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1. Oncotarget. 2016;7:36247-36254.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q. miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. J Biol Chem. 2011;286:25992-26002.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Wang H, Liu H, Chen K, et al. SIRT1 promotes tumorigenesis of hepatocellular carcinoma through PI3K/PTEN/AKT signaling. Oncol Rep. 2012;28:311-318.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Furnari FB, Huang HJ, Cavenee WK. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 1998;58:5002-5008.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Pinton G, Zonca S, Manente AG, et al. SIRT1 at the crossroads of AKT1 and ERbeta in malignant pleural mesothelioma cells. Oncotarget. 2016;7:14366-14379.</Citation>\n            </Reference>\n            <Reference>\n                <Citation>Yeung F, Ramsey CS, Popko-Scibor AE, et al. Regulation of the mitogen-activated protein kinase kinase (MEK)-1 by NAD(+)-dependent deacetylases. Oncogene. 2015;34:798-804.</Citation>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'